Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.
Company profile
Website
CEO
Heather M. Bresch
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
30336833
Latest filings (excl ownership)
424B5
Prospectus supplement for primary offering
5 Mar 07
424B3
Prospectus supplement
20 Feb 07
S-3ASR
Automatic shelf registration
20 Feb 07
424B3
Prospectus supplement
16 Dec 05
CORRESP
Correspondence with SEC
15 Dec 05
S-4
Registration of securities issued in business combination transactions
18 Nov 05
Latest ownership filings
No filings